Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Cocrystal Pharma appoints Carol Brosgart to board of directors

Cocrystal Pharma appoints Carol Brosgart to board of directors

ReutersReuters2026/08/17 15:17
  • Cocrystal Pharma appointed Carol Brosgart, MD to its board, effective Aug. 12, 2026.
  • Brosgart has several decades of experience in antiviral therapy, epidemiology, and biopharma advisory.
  • She spent more than a decade at Gilead Sciences, contributing to development and FDA approval of Viread and Hepsera.
  • She previously served as founding medical director of the East Bay AIDS Center at Alta Bates Medical Center in Berkeley.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608171117PRIMZONEFULLFEED9811281) on August 17, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!